Waaa, waaa... Are you serious? The plan hasn't changed... Rett before AD to secure the voucher. A partnership can't expedite approvals. Only data can do that. NDAs may come by YE. Partnerships will form for commercialization.
Sorry that you're over extended and didn't anticipate this manipulated takedown. Take a chill pill, dude! It'll all work out in the end... promise.
The patents are gonna be expired. That’s why partnering is the right move. Get the damn drugs out there and start helping people. Partner and get these FN trials moving!!
1. Several recent patents and applications that won't expire that soon, question is how valuable for IP protection those are, but unlikely to be the biggest issue Anavex have 2. No one will partner or buy into a biotech with no or soon lapsing patents
Way forward is a potential Rett approval and less likely AA in AD before anything like partnering, further indications etc. The rest of this year is crucial for Anavex and her investors. Another Feb'ish Rett readout would not imo be a good sign.
Jonjones--"Just go where you can get approved."--agree with everything you write--disgusted with TGD leadership--has gotton us here--damm sht sp level--thank you good dr//why not get approval downunder or Europe first if possible--stupid motive cause of more money here--if/when we get approved elsewhere FDA would be soon to follow---get to that finish line first where ever it may be---"excited as we are" BULLSHIT !!!!!!
"Missling said he is going to the fda first with Alz because they pay more. That’s a dumb azz move. "
Shouldn't the TGA be the first? This where the trials were they also received compassionate use and they were paying for part of it....I do not understand why no TGA submittal....scratching my head....